Akebia Therapeutics, Inc. (AKBA)
NASDAQ·Healthcare·Biotechnology
$1.25
-1.18%
Mkt Cap $327.27M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (3 analysts)
$4.00
Range $4.00 – $4.00
Implied Upside
+220.0%
Consensus $4.00 vs current $1.25
NASDAQ·Healthcare·Biotechnology
$1.25
-1.18%
Mkt Cap $327.27M
Buy
5
Hold
0
Sell
0
Price Target (3 analysts)
$4.00
Range $4.00 – $4.00
+220.0%
Consensus $4.00 vs current $1.25